Efficacy and Safety of Ruxolitinib Cream Monotherapy in Patients Aged 2 Years and Older With Mild-to-Moderate Atopic Dermatitis: Results From 3 Large Randomized Phase 3 Studies

Authors

Andrea Zaenglein MD

Publication/Presentation Date

2-2025

Volume

155

Issue

2

First Page

199

Last Page

199

Published In/Presented At

https://doi.org/10.1016/j.jaci.2024.12.618

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine Faculty

Document Type

Article